Kenvue (J4D) Stock Overview

Operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. More details

J4D fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	5/6
Financial Health	2/6
Dividends	3/6

Rewards

Trading at 45.9% below our estimate of its fair value

Earnings are forecast to grow 9.33% per year

Earnings grew by 53.6% over the past year

Risk Analysis

Shares are highly illiquid

Has a high level of debt

Dividend of 4.69% is not well covered by earnings

J4D Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

View all narratives

Kenvue Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Kenvue
Historical stock prices
Current Share Price	US$15.12
52 Week High	US$0
52 Week Low	US$0
Beta	0.50
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	5.24%

Recent updates

Shareholder Returns

	J4D	DE Personal Products	DE Market
7D	n/a	-1.1%	-1.5%
1Y	n/a	-10.8%	-0.4%

Return vs Industry: Insufficient data to determine how J4D performed against the German Personal Products industry.

Return vs Market: Insufficient data to determine how J4D performed against the German Market.

Price Volatility

Is J4D's price volatile compared to industry and market?
J4D volatility
J4D Average Weekly Movement	n/a
Personal Products Industry Average Movement	5.2%
Market Average Movement	6.0%
10% most volatile stocks in DE Market	12.9%
10% least volatile stocks in DE Market	2.7%

Stable Share Price: J4D's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine J4D's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2022	21,890	Kirk Perry	www.kenvue.com

Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women’s health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements.

Kenvue Inc. Fundamentals Summary

How do Kenvue's earnings and revenue compare to its market cap?
J4D fundamental statistics
Market cap	€29.50b
Earnings (TTM)	€1.41b
Revenue (TTM)	€13.27b

21.0x

P/E Ratio

2.2x

P/S Ratio

Is J4D overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
J4D income statement (TTM)
Revenue	US$15.29b
Cost of Revenue	US$6.33b
Gross Profit	US$8.96b
Other Expenses	US$7.34b
Earnings	US$1.62b

Last Reported Earnings

Mar 29, 2026

Next Earnings Date

n/a

Earnings per share (EPS)	0.84
Gross Margin	58.60%
Net Profit Margin	10.61%
Debt/Equity Ratio	81.6%

How did J4D perform over the long term?

See historical performance and comparison

Dividends

4.7%

Current Dividend Yield

98%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/06/07 19:36
End of Day Share Price	2026/06/05 00:00
Earnings	2026/03/29
Annual Earnings	2025/12/28

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Kenvue Inc. is covered by 19 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Lauren Lieberman	Barclays
Navann Ty Dietschi	BNP Paribas
Anna Lizzul	BofA Global Research

Kenvue Inc.XTRA:J4D Stock Report